United States of America v. INSYS Therapeutics, Inc.
United States District Court, Central District of CaliforniaApril 19, 20212:16-cv-07937California5,807 words
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT
CENTRAL DISTRICT OF CALIFORNIA
2 3 UNITED STATES OF AMERICA ex rel. CASE NO. (ASx) MELINA EBU-ISAAC and the States of 2:16-cv-07937-JLS-AJW CALIFORNIA, COLORADO, CONNECTICUT,
DELAWARE, FLORIDA, GEORGIA, HAWAII,
ILLINOIS, INDIANA, IOWA, LOUISIANA,
MASSACHUSETTS, MICHIGAN, Hon. Josephine L. Staton
MINNESOTA, MONTANA, NEVADA, NEW
MEXICO, NEW YORK, NORTH CAROLINA,
OKLAHOMA, RHODE ISLAND, TENNESSEE, TEXAS, VERMONT, PROTECTIVE ORDER VIRGINIA, WASHINGTON, the CITY OF 11 CHICAGO and the DISTRICT OF COLUMBIA, 12 Relator-Plaintiff, 14 v. 15 INSYS THERAPEUTICS, INC. and LINDEN
CARE, LLC, LINDEN CARE, INC., LINDEN
CARE HOLDINGS, INC., BELHEALTH
INVESTMENT PARTNERS, LLC, BEHEALTH INVESTMENT MANAGEMENT, LLC, and
BELHEALTH INVESTMENT FUND, LP
20 Defendants. 22 23 1. A. PURPOSES AND LIMITATIONS 24 Discovery in this action is likely to involve production of confidential, 25 proprietary, or private information for which special protection from public 26 disclosure and from use…